Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
1.51 USD | -1.31% | +11.03% | -14.20% |
Kurzporträt
Mitarbeiterzahl: 28
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 27.01.14 |
Leiv Lea
DFI | Director of Finance/CFO | 70 | 27.01.14 |
James Rosenbaum
CTO | Chief Tech/Sci/R&D Officer | - | 21.07.22 |
Gabriel Luciano
CTO | Chief Tech/Sci/R&D Officer | - | 01.01.18 |
Chief Tech/Sci/R&D Officer | - | 01.01.19 | |
William Jones
PRN | Corporate Officer/Principal | 59 | - |
Jeffrey Arcara
PRN | Corporate Officer/Principal | - | 06.02. |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 27.01.14 |
Ian Clark
BRD | Director/Board Member | 62 | 03.01.17 |
Terry Gould
BRD | Director/Board Member | 67 | 01.11.14 |
Peter Thompson
FOU | Founder | 64 | 27.01.14 |
Linda Grais
BRD | Director/Board Member | 68 | 28.01.19 |
Scott Morrison
BRD | Director/Board Member | 66 | 01.12.15 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 49 038 582 | 43 856 630 ( 89,43 %) | 0 | 89,43 % |
Unternehmenskontakt
Corvus Pharmaceuticals, Inc.
863 Mitten Road Suite 102
94010, Burlingame
+650 900 4520
http://www.corvuspharma.comSektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-14.20% | 74.05 Mio. | |
+4.09% | 43.84 Mrd. | |
+46.34% | 41.25 Mrd. | |
+9.45% | 41.68 Mrd. | |
-10.92% | 27.04 Mrd. | |
+9.32% | 25.53 Mrd. | |
-24.87% | 18.18 Mrd. | |
+29.70% | 12.29 Mrd. | |
+1.28% | 12.29 Mrd. | |
+7.78% | 11.15 Mrd. |
- Börse
- Aktien
- A2AFXS Aktie
- Unternehmen Corvus Pharmaceuticals, Inc.